...
首页> 外文期刊>European Journal of Cancer Supplements >1203 Pharmacokinetic and pharmacodynamic Phase I trial of ARQ 197 incorporating dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) studies investigating the antiangiogenic and antitumor activity of selective c-Met inhibition
【24h】

1203 Pharmacokinetic and pharmacodynamic Phase I trial of ARQ 197 incorporating dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) studies investigating the antiangiogenic and antitumor activity of selective c-Met inhibition

机译:结合动态对比增强(DCE)和扩散加权(DW)磁共振成像(MRI)研究的ARQ 197的1203药代动力学和药效学第一阶段试验,研究了选择性c-Met抑制的抗血管生成和抗肿瘤活性

获取原文
   

获取外文期刊封面封底 >>

       

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号